INJECTION SITE THROMBOSIS

This adverse event was reported 328 times

These drugs are most commonly taken by patients reporting INJECTION SITE THROMBOSIS:

# Drug Count
0 ADALIMUMAB 28
1 INTERFERON BETA-1A 14
2 PREDNISONE 13
3 ENOXAPARIN SODIUM 12
4 ACETAMINOPHEN 10
5 METFORMIN 10
6 METFORMIN ER 500 MG 10
7 METFORMIN ER 750 MG 10
8 OMEPRAZOLE MAGNESIUM 10
9 EVOLOCUMAB 9
See all common drugs associated with INJECTION SITE THROMBOSIS

INJECTION SITE THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 4 0.0058
1 Sclerosing Agent [EPC] 2 0.0044
2 Parenteral Iron Replacement [EPC] 8 0.0006
3 Histone Deacetylase Inhibitor [EPC] 2 0.0005
4 PCSK9 Inhibitor [EPC] 11 0.0004
5 Oxytocic [EPC] 1 0.0003
6 Photoenhancer [EPC] 1 0.0003
7 Sulfonamide Antibacterial [EPC] 1 0.0003
8 Human Immunoglobulin G [EPC] 5 0.0002
9 Interleukin-17A Antagonist [EPC] 8 0.0002
See all drug classes enriched for association with INJECTION SITE THROMBOSIS